Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Fahd Khalid-Salako has a total of 38 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Enterohemorrhagic Escherichia coli Detection by Aptamer-Functionalized Stokes-Shifted Quantum Dots

    by Fahd Khalid-Salako, Kaan Tiktaş, Hasan Kurt, Meral Yüce

    Escherichia coli O157:H7 is a prolific serotype of the Shiga toxin-producing E. coli strain, known for its enterohemorrhagic pathogenicity and transmission in contaminated food and water. The O157:H7 serotype, evolving from the nonpathogenic sorbitol-fermenting O55:H7 strain, is widely implicated as the causative organism in numerous food poisoning outbreaks reported globally. The public health implications of the spread of this pathogen necessitate its detection through field-deployable sensing systems, reproducible at scale. Accordingly, this study describes the development of a simple aptasensing setup based on magnetically separated Quantum Dots (QDs) with typical Stokes-shifted luminescence, decorated with an E. coli-specific aptamer sequence. The QD was covalently functionalized with the aptamer (Apt) by simple carbodiimide chemistry, producing a QD-Apt conjugate, and incubated with a cDNA-MB conjugate (produced by covalently functionalizing magnetic beads (MB) with a ssDNA sequence partially complementary to the aptamer), yielding the QD-Apt@cDNA-MB complex. Displacement of the cDNA-MB conjugate from the complex by cells of the pathogen, with which the QD-Apt binds with higher affinity, led to the loss of luminescence intensity in the magnetically separated supernatant containing the remaining QD-Apt@cDNA-MB construct (alongside the displaced cDNA-MB fragments), constituting the signal transduction mechanism of the E. coli detection system. The luminescent biosensor achieved a low detection limit (∼56 CFU · mL–1), high sensitivity, and specificity for the target pathogen, against other common food pathogens. The performance of the luminescent biosensor, in the absence of prior enrichment or sample concentration steps, renders it promising for large-scale environmental monitoring applications, toward the control of E. coli O157:H7 contamination.


  • Open Access

    Plasmon-Enhanced Raman Sensing with Metal–Insulator–Metal Metasurfaces

    by Sümeyra Vural Kaymaz, Fahd Khalid-Salako, Hasan Sarıgül, Beyza Nur Günaydın, Hasan Kurt, Meral Yüce

    Metal–insulator–metal (MIM) plasmonic metasurfaces provide a powerful platform for enhancing light-matter interactions; however, achieving simultaneous spectral tunability, fabrication reproducibility, and ultrasensitive detection remains a challenge. Here, we present the rational design, simulation, and lithographic fabrication of three distinct MIM metasurfaces (bowtie, honeycomb, and nanotriangle) optimized for plasmon-enhanced Raman spectroscopy (PERS). Finite-difference time domain (FDTD) simulations reveal localized surface plasmon resonances with electric field enhancement factors (EF) exceeding |E|2 ∼ 1600, supported by experimental reflection spectra and the fidelity of nanofabrication. Raman sensing of molecular probes (R6G, 4-ATP, 4-CTP) demonstrates analytical enhancement factors reaching 107 and detection limits as low as ∼10–15 M. This is made possible by the designed nanogap resonances, and the broadband localized surface plasmon resonance (LSPR) overlap with the excitation and scattering bands. Our findings establish the lithographically defined MIM metasurfaces as reliable, tunable, and ultrasensitive surface-enhanced Raman spectroscopy (SERS) platforms, making them suitable for next-generation portable chemical and biological sensing systems.


  • Open Access

    Experimental Optimization of a Plasmonic Surface Biofunctionalization, toward the Bimodal Biosensing and Kinetic Characterization of sPD1

    by Fahd Khalid-Salako, Hasan Kurt, Meral Yüce

    Soluble PD1 (sPD1) plays a complex role in cancer pathophysiology, reportedly dependent on its interactions with immune checkpoint proteins and therapeutic monoclonal antibodies. Yet, no biosensor platform currently affords simultaneous quantification and kinetic profiling of sPD1–antibody interactions. Here, we introduce a surface plasmon resonance (SPR) refractometric biosensor setup functionalized with nivolumab that integrates direct, label-free quantification and real-time functional analysis of sPD1 in a buffer and human serum. Sensor functionalization strategies and robust regeneration protocols were investigated and optimized. The biosensor achieved a limit of detection of 5 ng/mL (limit of quantification (LOQ) 8.7 ng/mL; dynamic range 8.7 ng/mL to 376 μg/mL) and quantified sPD1 with 93 ± 5% recovery in 1% serum and 62 ± 30% in 10% serum. Kinetic constants (k a ≈ 2.32 × 105 M–1 s–1; k d ≈ 1.03 × 10–3 s–1; K D ≈ 4.66 nM) match literature values for the nivolumab–PD1 interaction. This dual-mode SPR platform represents the first attempt to achieve two distinct analytical functions: (i) quantitative detection of soluble PD-1 (sPD1) and (ii) kinetic characterization of the sPD1–antibody interaction, in a single platform, within biological media. The emergent significance of sPD1 as a liquid biopsy biomarker in immuno-oncologic profiling positions this biosensor setup as a powerful tool for research and potential clinical monitoring of immune checkpoint dynamics.


  • Top Cited Papers
    Open Access

    The Nanocarrier Landscape─Evaluating Key Drug Delivery Vehicles and Their Capabilities: A Translational Perspective

    by Fahd Khalid-Salako, Soodeh Salimi Khaligh, Farzaneh Fathi, Osman C. Demirci, Nazlı Öncer, Hasan Kurt, Meral Yüce

    The field of nanomedicine is currently in a revolutionary phase, propelled by the significant potential of nanoparticles, which offer several advantages over traditional drug delivery systems. The purpose of this paper is to aggregate contemporary knowledge of nanoparticles developed and applied in drug delivery across major disease classes. Accordingly, we offer, through a thorough search of the literature, a comprehensive overview of the prevalent nanoparticles used in drug delivery systems, covering polymeric, lipid-based, inorganic, and carbon-based nanoparticles, and discuss their advantages and limitations. This work primarily focuses on studies published in the last 5 years, aiming to provide an up-to-date assessment of the critical nanoparticles in drug delivery. Narratively, we synthesize a comprehensive overview of the state-of-the-art in nanocarrier technology, providing in-depth insights into the key nanoparticle types presented in the contemporary literature, their fundamental benefits, potential clinical applications, and limitations impeding their development and adoption. We note that there are gaps and opportunities for concerted efforts focused on developing biocompatible and biodegradable nanoparticles, establishing scalable and cost-effective manufacturing processes, and addressing regulatory challenges associated with nanoparticle-based drug delivery systems. These challenges persist despite the immense translational success of nanoparticle-based drug delivery systems and necessitate continued interdisciplinary research and cross-industry collaboration among scientists, clinicians, and regulatory bodies.


  • Open Access

    Surface Plasmon Resonance Aptasensors: Emerging Design and Deployment Landscape

    by Fahd Khalid-Salako, Hasan Kurt, Meral Yüce

    SPR biosensors operate on the principle of evanescent wave propagation at metal–dielectric interfaces in total internal reflection conditions, with consequent photonic energy attenuation. This plasmonic excitation occurs in specific conditions of incident light wavelength, angle, and the dielectric refractive index. This principle has been the basis for SPR-based biosensor setups wherein mass/concentration-induced changes in the refractive indices of dielectric media reflect as plasmonic resonance condition changes quantitatively reported as arbitrary response units. SPR biosensors operating on this conceptual framework have been designed to study biomolecular interactions with real-time readout and in label-free setups, providing key kinetic characterization that has been valuable in various applications. SPR biosensors often feature antibodies as target affinity probes. Notably, the operational challenges encountered with antibodies have led to the development of aptamers—oligonucleotide biomolecules rationally designed to adopt tertiary structures, enabling high affinity and specific binding to a wide range of targets. Aptamers have been extensively adopted in SPR biosensor setups with promising clinical and industrial prospects. In this paper, we explore the growing literature on SPR setups featuring aptamers, specifically providing expert commentary on the current state and future implications of these SPR aptasensors for drug discovery as well as disease diagnosis and monitoring.


  • Open Access

    Exploring the Interaction of Biotinylated FcGamma RI and IgG1 Monoclonal Antibodies on Streptavidin-Coated Plasmonic Sensor Chips for Label-Free VEGF Detection

    by Soodeh Salimi Khaligh, Fahd Khalid-Salako, Hasan Kurt, Meral Yüce

    Vascular endothelial growth factor (VEGF) is a critical angiogenesis biomarker associated with various pathological conditions, including cancer. This study leverages pre-biotinylated FcγRI interactions with IgG1-type monoclonal antibodies to develop a sensitive VEGF detection method. Utilizing surface plasmon resonance (SPR) technology, we characterized the binding dynamics of immobilized biotinylated FcγRI to an IgG1-type antibody, Bevacizumab (AVT), through kinetic studies and investigated suitable conditions for sensor surface regeneration. Subsequently, we characterized the binding of FcγRI-captured AVT to VEGF, calculating kinetic constants and binding affinity. A calibration curve was established to analyze the VEGF quantification capacity and accuracy of the biosensor, computing the limits of blank, detection, and quantification at a 95% confidence interval. Additionally, the specificity of the biosensor for VEGF over other protein analytes was assessed. This innovative biomimetic approach enabled FcγRI-mediated site-specific AVT capture, establishing a stable and reusable platform for detecting and accurately quantifying VEGF. The results indicate the effectiveness of the plasmonic sensor platform for VEGF detection, making it suitable for research applications and, potentially, clinical diagnostics. Utilizing FcγRI-IgG1 antibody binding, this study highlights the industrial and clinical value of advanced biosensing technologies, offering insights to enhance therapeutic monitoring and improve outcomes in anti-VEGF therapies.


  • Open Access

    Tobacco Control in Sub-Saharan Africa: Challenges and Recommendations

    by Aishat Jumoke Alaran, Fahd Adebola Khalid-Salako, Yusuff Adebisi Adebayo, Abubakar Olaitan Badmos, Oluwaseyifunmi Oladipo, Zainab Oluwatosin Onibon, Don Eliseo Lucero-Prisno Iii

    According to the World Health Organization, more than 80% of the world’s current smokers live in low- and middle- income countries. In Sub-Saharan Africa (SSA), the increase in tobacco smoking is facilitated by the fast-growing population, increase in purchasing power of the consumers and massive efforts by the tobacco industry to expand their reach in this region. Until the World Health Organization’s Framework Convention on Tobacco Control (FCTC), many countries in SSA had weak or non-existent tobacco control policies, about 44 countries in the region are currently signatories to the treaty. Despite being signatories to the FCTC, many sub-Saharan African countries have not been able to implement and/or enforce comprehensive tobacco control policies. This chapter is intended to share the challenges facing existing public health advocacy and interventions against tobacco smoking in SSA countries and to make recommendations necessary to control tobacco smoking in the SSA countries.


  • Antifungal Potential of Some Nigerian Indigenous Plants: A Remedy for Candidiasis

    by Mercy I. Aboh, Japhet G. Yakubu, Jude U. Eze, Fahd Khalid-Salako, Peters O. Oladosu

    Background: Invasive candidiasis has been recognized as a major cause of mortality and morbidity in hospital settings across the globe. Aside from C. albicans, other Candida species (C. glabarata, C. parapsilosis, and C. tropicalis) associated with invasive candidiasis have been reported as a public health challenge. Objective: This study aimed to evaluate the antifungal activities of extracts of some indigenous plants using the agar disc diffusion method. Methods: Fresh samples of the plant parts were collected, identified, air dried, pulverized and extracted using standard methods. The extracts were screened against clinical isolates of C. albicans, C. glabarata, C. parapsilosis and C. tropicalis using agar disc diffusion method. Results: All plant extracts exhibited varying inhibition zones ranging from 8.0 - 24.0 mm against the tested isolates. Fractions of Acalypha wilkesiana Macrophylla (AWRF5) showed the lowest activities against all the test isolates with zones of inhibition ranging from 10.0-13.0 mm while AWRF6 fraction of the same plant demonstrated highest antifungal activities against all the test isolates with zones of inhibition ranging from 14.0-24 mm followed by fractions of Acalypha wilkesiana Hoffmanii (AWGF6), which demonstrated high (14.0 - 20.0 mm) antifungal activities. Conclusion: The Plants understudied possessed antifungal potentials and can serve as lead in the development of phytomedicines to combat candidiasis decrease medical as well as financial burden, hence improving the management of cirrhotic patients. These predictors, however, need further work to validate reliability.


  • Open Access

    Uneven power dynamics must be levelled in COVID-19 vaccines access and distribution

    by Aishat Jumoke Alaran, Yusuff Adebayo Adebisi, Abubakar Badmos, Fahd Khalid-Salako, Sa’iD Khalid Gaya, Esther Bosede Ilesanmi, Damilola Quazeem Olaoye, Adeola Bamisaiye, Don Eliseo Lucero-Prisno